This drug functions by inhibiting the formation of homologous/heterodimeric complexes within the HER family and suppressing autophosphorylation, effectively blocking the activation of signaling pathways such as RAS/RAF/MEK/MAPK, PI3K/AKT, and the G1-phase tumor cell cycle. The gene discussed is PIK3CA; the disease is neoplasm.